Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators

Kenneth C. Bilchick; Yongfei Wang; Alan Cheng; Jeptha P. Curtis; Kumar Dharmarajan; George J. Stukenborg; Ramin Shadman; Inder S. Anand; Lars H. Lund; Ulf Dahlström; Ulrik Sartipy; Aldo Maggioni; Karl Swedberg; Chris O’Conner; Wayne C. Levy

doi:10.1016/j.jacc.2017.03.568

Related publications

Article2015

A novel method to predict the proportional risk of sudden cardiac death in heart failure: Derivation of the Seattle Proportional Risk Model

Ramin Shadman, Jeanne E. Poole, Todd Dardas, Dariush Mozaffarian, John G.F. Cleland, Karl Swedberg, Aldo Maggioni, Inder S. Anand, Peter E. Carson, Alan B. Miller, Wayne C. Levy

Article2010

Implantable Cardioverter-Defibrillators in Patients Hospitalized for Heart Failure With Chronically Reduced Left Ventricular Ejection Fraction

Norman C. Wang, Jonathan P. Piccini, Marvin A. Konstam, Aldo Maggioni, Brian Traver, Karl Swedberg, James E. Udelson, Faı̈ez Zannad, Thomas D. Cook, Christopher M. O’Connor, Alan B. Miller, Liliana Grinfeld, Mihai Gheorghiade

Article2009

Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population

Wayne C. Levy, Kerry L. Lee, Anne S. Hellkamp, Jeanne E. Poole, Dariush Mozaffarian, David T. Linker, Aldo Maggioni, Inder S. Anand, Philip A. Poole‐Wilson, Daniel P. Fishbein, George Johnson, Jill Anderson, Daniel B. Mark, Gust H. Bardy

Article2018

Effect of Implantable Cardioverter-Defibrillators by Etiology of Heart Failure: A Propensity-Matched Mortality Analysis of the WARCEF Trial

Tetz C. Lee, Min Qian, Lan Mu, Marco R. Di Tullio, Susan Graham, Dougla L. Mann, Koki Nakanishi, John R. Teerlink, Professor Gregory Lip, Ronald S. Freudenberger, Ralph L. Sacco, J.P. Mohr, Arthur J. Labovitz, Piotr Ponikowski, Dirk J. Lok, Conrado J. Estol, Stefan D. Anker, Patrick M. Pullicino, Richard Buchsbaum, Bruce Levin, John L.P. Thompson, Shunichi Homma,

Article2019

Association Between Mortality and Implantable Cardioverter-Defibrillators by Aetiology of Heart Failure: A Propensity-Matched Analysis of the WARCEF Trial

Tetz C. Lee, Min Qian, Lan Mu, Marco R. Di Tullio, Susan Graham, Douglas L. Mann, Koki Nakanishi, John R. Teerlink, Professor Gregory Lip, Ronald S. Freudenberger, Ralph L. Sacco, J.P. Mohr, Arthur J. Labovitz, Piotr Ponikowski, Dirk J. Lok, Conrado J. Estol, Stefan D. Anker, Patrick M. Pullicino, Richard Buchsbaum, Bruce Levin, John L.P. Thompson, Shunichi Homma,

Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators

Discussion(0)